The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Practical applications and feasibility of efflux pump inhibitors in the clinic—A vision for applied use
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Koronakis, V., Sharff, A., Koronakis, E., Luisi, B., & Hughes, C. (2000) · Nature · doi:10.1038/35016007 · Cited by 1,086
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Crystal structure of bacterial multidrug efflux transporter AcrB
Murakami, S., Nakashima, R., Yamashita, E., & Yamaguchi, A. (2002) · Nature · doi:10.1038/nature01050 · Cited by 986
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Drusano, G. L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro862 · Cited by 930
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Self-citationTrends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3322-3327.2000 · Cited by 722
Efflux-mediated multiresistance in Gram-negative bacteria
Poole, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00763.x · Cited by 613
Tseng, T., Gratwick, K. S., Kollman, J. M., Park, D., Nies, D. H., Goffeau, A., & Saier, M. H. (1999) · PubMed · Cited by 598
46th Interscience Conference on Antimicrobial Agents and Chemotherapy
McConnell, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70621-1 · Cited by 541
Molecular Analysis of the Copper-Transporting Efflux System CusCFBA of Escherichia coli
Franke, S., Grass, G., Rensing, C., & Nies, D. H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.13.3804-3812.2003 · Cited by 538
Active efflux mechanisms for antimicrobial resistance
Levy, S. B. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.695 · Cited by 503
Multidrug resistance mechanisms: drug efflux across two membranes
Zgurskaya, H. I., & Nikaido, H. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01926.x · Cited by 466
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa
Rossolini, G. M., & Mantengoli, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01161.x · Cited by 395
Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump
Yu, E. W., McDermott, G., Zgurskaya, H. I., Nikaido, H., & Koshland, D. E. (2003) · Science · doi:10.1126/science.1083137 · Cited by 392
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
Resistance to ?-lactam antibiotics
Poole, K. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4060-9 · Cited by 358
Phylogeny of multidrug transporters
Saier, Jr., & Paulsen, I. T. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0246 · Cited by 333
Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria
Nikaido, H. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0247 · Cited by 317
The Glycylcyclines: A Comparative Review with the Tetracyclines
Zhanel, G. G., Homenuik, K., Nichol, K., Noreddin, A., Vercaigne, L., Embil, J., Gin, A., Karlowsky, J. A., & Hoban, D. J. (2004) · Drugs · doi:10.2165/00003495-200464010-00005 · Cited by 306
Schweizer, H. P. (2003) · PubMed · Cited by 287
Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., & Plésiat, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1797-1802.2004 · Cited by 277
Ziha-Zarifi, I., Llanes, C., Köhler, T., Pechere, J.-C., & Plesiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.287 · Cited by 276
Bacterial efflux systems and efflux pumps inhibitors
Marquez, B. (2005) · Biochimie · doi:10.1016/j.biochi.2005.04.012 · Cited by 270
AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex
Tikhonova, E. B., & Zgurskaya, H. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402230200 · Cited by 270
Lee, A., Mao, W., Warren, M. S., Mistry, A., Hoshino, K., Okumura, R., Ishida, H., & Lomovskaya, O. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.11.3142-3150.2000 · Cited by 263
Self-citationAkama, H., Matsuura, T., Kashiwagi, S., Yoneyama, H., Narita, S.-I., Tsukihara, T., Nakagawa, A., & Nakae, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400164200 · Cited by 255
Structure of the periplasmic component of a bacterial drug efflux pump
Higgins, M. K., Bokma, E., Koronakis, E., Hughes, C., & Koronakis, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400375101 · Cited by 254
Drusano, G. L., Preston, S. L., Fowler, C., Corrado, M., Weisinger, B., & Kahn, J. (2004) · The Journal of Infectious Diseases · doi:10.1086/383320 · Cited by 245
Inhibitors of efflux pumps in Gram-negative bacteria
Pagès, J.-M., Masi, M., & Barbe, J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.006 · Cited by 238
Jumbe, N., Louie, A., Leary, R., Liu, W., Deziel, M. R., Tam, V. H., Bachhawat, R., Freeman, C., Kahn, J. B., Bush, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16814 · Cited by 238
Jumbe, N., Louie, A., Leary, R., Liu, W., Deziel, M. R., Tam, V. H., Bachhawat, R., Freeman, C., Kahn, J. B., Bush, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316814 · Cited by 236
Bohnert, J. A., & Kern, W. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.849-852.2005 · Cited by 226
Tigecycline: A New Glycylcycline for Treatment of Serious Infections
Noskin, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/431672 · Cited by 226
Nikaido, H., Basina, M., Nguyen, V., & Rosenberg, E. Y. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.17.4686-4692.1998 · Cited by 224
Antibiotics: Where did we go wrong?
Overbye, K. M., & Barrett, J. F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03285-4 · Cited by 223
Crystal Structure of the Drug Discharge Outer Membrane Protein, OprM, of Pseudomonas aeruginosa
Akama, H., Kanemaki, M., Yoshimura, M., Tsukihara, T., Kashiwagi, T., Yoneyama, H., Narita, S.-I., Nakagawa, A., & Nakae, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400445200 · Cited by 220
Lomovskaya, O., Lee, A., Hoshino, K., Ishida, H., Mistry, A., Warren, M. S., Boyer, E., Chamberland, S., & Lee, V. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1340 · Cited by 220
Self-citationFirsov, A. A., Vostrov, S. N., Lubenko, I. Y., Drlica, K., Portnoy, Y. A., & Zinner, S. H. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1604-1613.2003 · Cited by 215
Interactions underlying assembly of the Escherichia coli AcrAB–TolC multidrug efflux system
Touzé, T., Eswaran, J., Bokma, E., Koronakis, E., Hughes, C., & Koronakis, V. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04158.x · Cited by 205
Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
Pai, H., Kim, J.-W., Kim, J., Lee, J. H., Choe, K. W., & Gotoh, N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.480-484.2001 · Cited by 205
Hoban, D. J., Bouchillon, S. K., Johnson, B. M., Johnson, J. L., & Dowzicky, M. J. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.06.001 · Cited by 204
Van Bambeke, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg224 · Cited by 203
Outer Membranes and Efflux: The Path to Multidrug Resistance in Gram- Negative Bacteria
Poole, K. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378454 · Cited by 198
Yu, E. W., Aires, J. R., & Nikaido, H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.19.5657-5664.2003 · Cited by 191
Zgurskaya, H. I., & Nikaido, H. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.15.4264-4267.2000 · Cited by 167
Mushtaq, S., Ge, Y., & Livermore, D. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3086-3092.2004 · Cited by 164
Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.
Lomovskaya, O., & Watkins, W. (2001) · PubMed · Cited by 161
Self-citationChimeric Analysis of the Multicomponent Multidrug Efflux Transporters from Gram-Negative Bacteria
Tikhonova, E. B., Wang, Q., & Zgurskaya, H. I. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.23.6499-6507.2002 · Cited by 160
Amin, N. M. E., Giske, C. G., Jalal, S., KEIJSER, B., Kronvall, G., & Wretlind, B. (2005) · Apmis · doi:10.1111/j.1600-0463.2005.apm1130306.x · Cited by 142
Kriengkauykiat, J., Porter, E. M., Lomovskaya, O., & Wong‐Beringer, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.565-570.2005 · Cited by 137
Self-citationHasdemir, U. O., Chevalier, J., Nordmann, P., & Pagès, J.-M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2701-2706.2004 · Cited by 131
Mao, W., Warren, M. S., Black, D. S., Sato, T., Murata, T., Nishino, T., Gotoh, N., & Lomovskaya, O. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03223.x · Cited by 127
Self-citationTaking inventory: antibacterial agents currently at or beyond Phase 1
Bush, K., Macielag, M. J., & Weidner‐Wells, M. A. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.08.013 · Cited by 126
. . . from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy.
Mouton, Y. (2000) · PubMed · Cited by 124
Malléa, M., Mahamoud, A., Chevalier, J., Alibert, S., Brouant, P., Barbe, J., & Pagès, J. (2003) · Biochemical Journal · doi:10.1042/bj20030963 · Cited by 117
Antibacterial drug discovery in the 21st century
Bush, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1465-0691.2004.1005.x · Cited by 106
Chevalier, J., Bredin, J., Mahamoud, A., Malléa, M., Barbe, J., & Pagès, J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.1043-1046.2004 · Cited by 104
Yu, J., Grinius, L., & Hooper, D. C. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.5.1370-1377.2002 · Cited by 103
Elkins, C. A., & Nikaido, H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.18.5349-5356.2003 · Cited by 100
Payot, S., Avrain, L., Magras, C., Praud, K., Cloeckaert, A., & Chaslus-Dancla, E. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.008 · Cited by 99
Middlemiss, J. K., & Poole, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.5.1258-1269.2004 · Cited by 99
Renau, T. E., Léger, R., FILONOVA, L. K., Flamme, E. M., Wang, M., Yen, R., Madsen, D., Griffith, D. E., Chamberland, S., Dudley, M. N., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00556-0 · Cited by 98
Self-citationMultidrug-exporting secondary transporters
Murakami, S., & Yamaguchi, A. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00109-x · Cited by 97
Nakayama, K., Ishida, Y., Ohtsuka, M., Kawato, H. C., Yoshida, K., Yokomizo, Y., Hosono, S., Ohta, T., Hoshino, K., Ishida, H., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.024 · Cited by 86
Chevalier, J., Atifi, S., Eyraud, A., Mahamoud, A., Barbe, J., & Pagès, J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010911z · Cited by 85
Sáenz, Y. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh117 · Cited by 85
İnce, D., Zhang, X., Silver, L. C., & Hooper, D. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3370-3380.2002 · Cited by 80
Renau, T. E., Léger, R., Yen, R., She, M. W., Flamme, E. M., Sangalang, J. C., Gannon, C. L., Chamberland, S., Lomovskaya, O., & LEE, V. J. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00006-9 · Cited by 78
Self-citationWatkins, W. J., Landaverry, Y. R., Léger, R., Litman, R., Renau, T. E., Williams, N., Yen, R., Zhang, J. Z., Chamberland, S., Madsen, D., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.030 · Cited by 78
Efflux in bacteria: what do we really know about it?
Ryan, B., Dougherty, T. J., Beaulieu, D., Chuang, J., Dougherty, B. A., & Barrett, J. F. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.8.1409 · Cited by 76
Fritsche, T. R., Strabala, P., Sader, H. S., Dowzicky, M. J., & Jones, R. N. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.06.010 · Cited by 75
Giraud, É., Blanc, G., Bouju-Albert, A., Weill, F., & Donnay‐Moreno, C. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45579-0 · Cited by 71
İnce, D., & Hooper, D. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2755-2764.2001 · Cited by 71
Baucheron, S., Mouline, C., Praud, K., Chaslus-Dancla, E., & Cloeckaert, A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki091 · Cited by 69
Nehme, D., Li, X.-Z., Elliot, R., & Poole, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.10.2973-2983.2004 · Cited by 69
Nakayama, K., Kawato, H. C., Watanabe, J., Ohtsuka, M., Yoshida, K., Yokomizo, Y., Sakamoto, A., Kuru, N., Ohta, T., Hoshino, K., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.060 · Cited by 66
Mamelli, L. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00199-7 · Cited by 65
Bacterial efflux pump inhibition.
Kaatz, G. W. (2005) · PubMed · Cited by 64
Nakayama, K., Ishida, Y., Ohtsuka, M., Kawato, H. C., Yoshida, K., Yokomizo, Y., Ohta, T., Hoshino, K., Otani, T., Kurosaka, Y., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.027 · Cited by 59
3-Arylpiperidines as potentiators of existing antibacterial agents
Thorarensen, A., Presley, A. L., Marotti, K. R., Boyle, T. P., Heckaman, C. L., Bohanon, M. J., Tomich, P. K., Zurenko, G. E., Sweeney, M. T., & Yagi, B. H. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00330-4 · Cited by 57
Okamoto, K., Gotoh, N., & Nishino, T. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2696-2699.2002 · Cited by 54
Ip, H., Stratton, K., Zgurskaya, H. I., & Liu, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305152200 · Cited by 52
Elkins, C. A., & Nikaido, H. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00004-9 · Cited by 51
Nakayama, K., Kuru, N., Ohtsuka, M., Yokomizo, Y., Sakamoto, A., Kawato, H. C., Yoshida, K., Ohta, T., Hoshino, K., Akimoto, K., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.007 · Cited by 51
In Vitro Activity of the New Quinolone WCK 771 against Staphylococci
Jacobs, M. R., Bajaksouzian, S., Windau, A., Appelbaum, P. C., Patel, M. V., Gupte, S. V., Bhagwat, S., de Souza, N. J., & Khorakiwala, H. F. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3338-3342.2004 · Cited by 49
Structural understanding of efflux-mediated drug resistance: potential routes to efflux inhibition
McKeegan, K. S., Borges-Walmsley, M. I., & Walmsley, A. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.07.002 · Cited by 39
Gallo, S. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00215-2 · Cited by 35
Topoisomerase Targeting with and Resistance to Gemifloxacin in Staphylococcus aureus
İnce, D., Zhang, X., Silver, L. C., & Hooper, D. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.274-282.2003 · Cited by 29
Drug abuse: from gene through cell to behaviour
Henderson, G., Morton, J. R., & Little, H. J. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.11.002 · Cited by 21
Crossing the envelope: how cephalosporins reach their targets
Nikaido, H. (2000) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2000.tb02036.x · Cited by 19
Mechanistic Parallels in Bacterial and Human Multidrug Efflux Transporters
Zgurskaya, H. I., & Nikaido, H. (2002) · Current Protein and Peptide Science · doi:10.2174/1389203023380512 · Cited by 19
Cited by
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Metadata
- Authors
- Lomovskaya, O., & Bostian, K. A.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 71
- Issue
- 7
- Pages
- 910-918
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2079530723
- Cited by
- 460
- References
- 97
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.